Verified By March 18, 2024
Verified by Dr. Punit Jain – Consultant Hematology, Program Coordinator & Transplant Physician and Dr. Vipin Khandelwal – Consultant Pediatric Hemato- Oncology at Apollo Cancer Centers in Navi Mumbai.
Exciting news for cancer patients in India! CAR T-cell therapy, a revolutionary treatment using genetically modified immune cells, is now available domestically. This marks a significant step forward in offering advanced options for battling tough-to-treat cancers.
What is CAR T-cell therapy?
Imagine training your body’s own immune system to become an army specifically targeting cancer cells. That’s the essence of CAR T-cell therapy. Here’s a breakdown of the process:
Benefits and Availability
A “Made in India” CAR-T program, NexCAR19™, is currently available at Apollo Cancer Centres in Navi Mumbai, catering to adults and adolescents above 15 years old.
Hope for the Future
The arrival of CAR T-cell therapy in India is a significant development. While currently focused on specific cancers, research is ongoing to expand its application to other types. This innovative treatment holds immense potential for improving patient outcomes and offering a brighter future for cancer care in India.
Consult our experts, Dr. Punit Jain – Consultant Hematology, Program Coordinator & Transplant Physician and Dr. Vipin Khandelwal – Consultant Pediatric Hemato- Oncology at Apollo Cancer Centres in Navi Mumbai for more information.
Call 022 6280 6280 for an appointment.
August 26, 2024
August 26, 2024
April 18, 2024